Affinity Asset Advisors, LLC Context Therapeutics Inc. Transaction History
Affinity Asset Advisors, LLC
- $896 Million
- Q1 2025
A detailed history of Affinity Asset Advisors, LLC transactions in Context Therapeutics Inc. stock. As of the latest transaction made, Affinity Asset Advisors, LLC holds 660,589 shares of CNTX stock, worth $422,776. This represents 0.04% of its overall portfolio holdings.
Number of Shares
660,589
Previous 1,015,340
34.94%
Holding current value
$422,776
Previous $1.01 Million
60.0%
% of portfolio
0.04%
Previous 0.18%
Shares
8 transactions
Others Institutions Holding CNTX
# of Institutions
47Shares Held
79MCall Options Held
0Put Options Held
0-
Bio Impact Capital LLC Cambridge, MA14.7MShares$9.41 Million1.66% of portfolio
-
Avidity Partners Management LP Dallas, TX7.48MShares$4.79 Million1.03% of portfolio
-
Deep Track Capital, LP Greenwich, CT7.42MShares$4.75 Million0.16% of portfolio
-
Nextech Invest Ag7.42MShares$4.75 Million1.37% of portfolio
-
Nextech Invest, Ltd. Zurich, V87.42MShares$4.75 Million1.06% of portfolio
About Context Therapeutics Inc.
- Ticker CNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 15,966,100
- Market Cap $10.2M
- Description
- Context Therapeutics Inc., a clinical-stage biopharmaceutical company, develops products for the treatment of cancer for women in the United States. Its lead product candidate is onapristone extended release (ONA-XR), a potent and selective antagonist of the progesterone receptor that is linked to resistance for various classes of cancer therape...